Dopamine Receptor Subtypes Selectively Modulate Excitatory Afferents from the Hippocampus and Amygdala to Rat Nucleus Accumbens Neurons

被引:0
|
作者
A Charara
A A Grace
机构
[1] University of Pittsburgh,Departments of Neuroscience and Psychiatry
来源
Neuropsychopharmacology | 2003年 / 28卷
关键词
nucleus accumbens; dopamine; hippocampus; amygdala; afferents;
D O I
暂无
中图分类号
学科分类号
摘要
The nucleus accumbens (NAc) receives excitatory afferents from several cortical and limbic regions and dense dopaminergic inputs from the ventral tegmental area. We examined the effects of dopamine (DA) D1 and D2 selective drugs on the responses evoked in the NAc shell neurons recorded in vitro by stimulation of hippocampal and amygdaloid afferents. Activation of hippocampal and amygdaloid afferents induced excitatory postsynaptic responses that were depressed by bath application of DA in most of the cells recorded. The DA effect was substantially blocked by the D1 receptor antagonist SCH 23390, but not by the D2 receptor antagonist eticlopride. Moreover, the D1 receptor agonist SKF 38393, but not the D2 receptor agonist quinpirole, mimicked the effects of DA, although a small population of neurons exhibited a D1-mediated facilitation of the EPSP amplitude following fornix stimulation. These data demonstrate a DA receptor subtype-specific modulation of glutamatergic inputs to the NAc, with D1 agonists attenuating amygdaloid inputs, whereas hippocampal-evoked responses were either depressed or potentiated by D1 stimulation. Such facilitation or attenutation of hippocampal afferents against a background of suppression of other afferents would permit the hippocampus to have a dominant influence over behavior during periods of exploration.
引用
收藏
页码:1412 / 1421
页数:9
相关论文
共 50 条
  • [41] Glutamate receptor-dependent modulation of dopamine efflux in the nucleus accumbens by basolateral, but not central, nucleus of the amygdala in rats
    Howland, JG
    Taepavarapruk, P
    Phillips, AG
    JOURNAL OF NEUROSCIENCE, 2002, 22 (03): : 1137 - 1145
  • [42] SYNAPTIC-INTERACTIONS AMONG EXCITATORY AFFERENTS TO NUCLEUS-ACCUMBENS NEURONS - HIPPOCAMPAL GATING OF PREFRONTAL CORTICAL INPUT
    ODONNELL, P
    GRACE, AA
    JOURNAL OF NEUROSCIENCE, 1995, 15 (05): : 3622 - 3639
  • [43] GLUTAMATE RECEPTOR SUBTYPES MEDIATE EXCITATORY SYNAPTIC CURRENTS OF DOPAMINE NEURONS IN MIDBRAIN SLICES
    MEREU, G
    COSTA, E
    ARMSTRONG, DM
    VICINI, S
    JOURNAL OF NEUROSCIENCE, 1991, 11 (05): : 1359 - 1366
  • [44] Mianserin markedly and selectively increases extracellular dopamine in the prefrontal cortex as compared to the nucleus accumbens of the rat
    Tanda, G
    Bassareo, V
    DiChiara, G
    PSYCHOPHARMACOLOGY, 1996, 123 (02) : 127 - 130
  • [45] Neuropeptide Y receptor subtypes in the basolateral. nucleus of the amygdala modulate anxiogenic responses in rats
    Sajdyk, TJ
    Schober, DA
    Gehlert, DR
    NEUROPHARMACOLOGY, 2002, 43 (07) : 1165 - 1172
  • [46] Dopamine receptor modulation in nucleus accumbens neurons: Implications for ethanol self-administration
    Hopf, FW
    Cascini, MG
    Mailliard, WS
    Gonzalez, GF
    Yao, L
    Jiang, Z
    Gordon, AS
    Diamond, I
    Bonci, A
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2004, 28 (05) : 182A - 182A
  • [47] Role of nucleus accumbens dopamine receptor subtypes in the learning and expression of alcohol-seeking behavior
    Young, Emily A.
    Dreumont, Sarah E.
    Cunningham, Christopher L.
    NEUROBIOLOGY OF LEARNING AND MEMORY, 2014, 108 : 28 - 37
  • [48] Glutamate receptor agonists decrease extracellular dopamine in the rat nucleus accumbens in vivo
    Taber, MT
    Baker, GB
    Fibiger, HC
    SYNAPSE, 1996, 24 (02) : 165 - 172
  • [49] A2A adenosine receptor modulation of dopamine release in the rat nucleus accumbens
    Harper, LK
    Beckett, SR
    Marsden, CA
    Alexander, SPA
    JOURNAL OF PSYCHOPHARMACOLOGY, 2002, 16 (03) : A61 - A61
  • [50] Gradient of dopamine responsiveness to doparnine receptor agonists in subregions of the rat nucleus accumbens
    Shilliam, CS
    Heidbreder, CA
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 477 (02) : 113 - 122